Takehara N, Matsubara H. Cardiac regeneration therapy: connections to cardiac physiology. Am J Physiol Heart Circ Physiol 301: H2169–H2180, 2011. First published September 30, 2011; doi:10.1152/ajpheart.00768.2011.—Without heart transplantation, a large number of patients with failing hearts worldwide face poor outcomes. By means of cardiomyocyte regeneration, cardiac regeneration therapy is em...

AIMS To establish the effects of relaxation therapy on the recovery from a cardiac ischaemic event and secondary prevention. METHODS AND RESULTS A search was conducted for controlled trials in which patients with myocardial ischaemia were taught relaxation therapy, and outcomes were measured with respect to physiological, psychological, cardiac effects, return to work and cardiac events. A to...

BACKGROUND Studies of cardiac resynchronization therapy in addition to an implantable cardioverter defibrillator in patients with mild to moderate congestive heart failure had not been shown to reduce mortality until the recent RAFT trial (Resynchronization/Defibrillation for Ambulatory Heart Failure Trial). We performed a meta-analysis including the RAFT trial to determine the effect of cardia...

Cardiac resynchronization therapy improves clinical symptoms and prognosis of heart failure patients. However, it has been shown that up to 40% of patients do not respond to this therapy. Three main determinants of cardiac resynchronization therapy response have been identified: left ventricular dyssynchrony, left ventricular lead position, and extent and location of myocardial scar tissue. Two...

BACKGROUND Cardiac resynchronization therapy (CRT) is a medical device to help cardiac synchronized contractility by electrical impulses. Improvement of symptoms and left ventricular systolic function, reducing hospital admissions and mortality in patients with moderate to severe heart failure are the main benefits of administration of cardiac resynchronization therapy. CASE REPORT In this ar...

High rates of cardiovascular (CV) morbidity and mortality dictates the need to determine approaches therapy that would reduce complications rate improve patient’s prognosis. High-intensity statin is an integral part treatment patients with high very risk. At same time, there a large cohort who benefit from moderate intensity therapy. In present article we have summarized available data on hypol...

Haemopericardium has rarely been described in association with the use of a non-vitamin K antagonist oral anticoagulant. Cardiac tamponade is life-threatening condition that usually requires urgent pericardiocentesis. Here, authors report case haemopericardium cardiac during dabigatran therapy for atrial fibrillation patient chronic coronary syndrome, treated effectively reversal agent idaruciz...

background: patients with psychological problems after coronary artery bypass graft surgery (cabg) show poorer outcomes; nevertheless, there is a paucity of research into the effects of cardiac rehabilitation programs on such patients. the purpose of this study was to determine the effect of phase iii cardiac rehabilitation programs on the anxiety and quality of life of anxious patients who had...

The thickness of epicardial adipose tissue (EAT) has the potential to act as a novel indicator cardiac and visceral adiposity its function in myocardial infarction (MI) diagnosis therapy.

Cardiac toxicity is a dose-limiting toxicity that may occur during cancer treatment or several years after therapy ends. Cardiac toxicity may be caused by chemotherapy, biotherapy, and radiation therapy and may result in cardiomyopathy, congestive heart failure, dysrhythmias, and myocardial ischemia. The risk for developing cardiac toxicity varies based on type of treatment, patient age, presen...